financetom
Business
financetom
/
Business
/
Real estate welcomes the overdue repo rate cut by RBI
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Real estate welcomes the overdue repo rate cut by RBI
Feb 7, 2019 3:32 AM

The Reserve Bank of India's (RBI) decision to slash the repo rate by 25 basis point to 6.25 percent is a welcome and unexpectedly positive move, given the sops that the recent expansionary budget gave to farmers at an additional cost of Rs 75,000 crore per annum.

It was also overdue, as this has been the first cut in a long time. It definitely augurs well for the real estate sector, which also received a budget bonanza in the previous week.

Rate cuts give a substantial push to property buyer sentiments, and it was certainly high time for such a cut. Home loan interest rates increased by as much as 5-7 percent in the last one year as the RBI hiked its repo rates by 50 basis points over the same period. In other words, home loans had become a more expensive proposition.

However, the real estate market does not depend only on marginally improved buyer sentiment - there are larger issues that hold the sector hostage right now. The liquidity issues post the non-banking finance company (NBFC) crisis are a bigger concern. NBFCs and housing finance companies (HFCs) have seriously curtailed disbursements to developers. Moreover, the repayment capabilities of many developers are also in question.

Furthermore, though the account deficit (CAD) widened to 2.9 percent in December, inflation targets are more or less within control and the GDP is estimated to grow at a very healthy 7.5 percent in the new fiscal. Going by these indicators, the Indian economy is looking at a good financial year ahead - always assuming that a stable government is voted to power in the upcoming general elections.

Anuj Puri is the chairman of ANAROCK Property Consultants.

First Published:Feb 7, 2019 12:32 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Applied Digital Fiscal Q1 Non-GAAP Loss Widens, Revenue Rises
Applied Digital Fiscal Q1 Non-GAAP Loss Widens, Revenue Rises
Oct 9, 2025
04:34 PM EDT, 10/09/2025 (MT Newswires) -- Applied Digital ( APLD ) reported a fiscal Q1 adjusted net loss late Thursday of $0.03 per diluted share, widening from the loss of $0.01 a year earlier. Four analysts polled by FactSet expected a loss of $0.16. Revenue in the three months ended Aug. 31 rose to $64.2 million from $34.8 million...
USANA Health Sciences Preliminary Q3 Swings to Loss, Net Sales Rise
USANA Health Sciences Preliminary Q3 Swings to Loss, Net Sales Rise
Oct 9, 2025
04:33 PM EDT, 10/09/2025 (MT Newswires) -- USANA Health Sciences ( USNA ) reported fiscal Q3 preliminary adjusted loss late Thursday of $0.15, swinging from earnings of $0.56 a year earlier. Two analysts polled by FactSet expected earnings of $0.56. Preliminary net sales for the quarter ended Sept. 27 were $214 million, up from $200 million a year earlier. Two...
Zivo Bioscience Insider Bought Shares Worth $284,421, According to a Recent SEC Filing
Zivo Bioscience Insider Bought Shares Worth $284,421, According to a Recent SEC Filing
Oct 9, 2025
04:33 PM EDT, 10/09/2025 (MT Newswires) -- Christopher D. Maggiore, 10% Owner, Director, on October 08, 2025, executed a purchase for 23,682 shares in Zivo Bioscience ( ZIVO ) for $284,421. Following the Form 4 filing with the SEC, Maggiore has control over a total of 517,526 common shares of the company, with 517,526 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1101026/000165495425011614/xslF345X05/section16.xml...
Nurix Therapeutics Fiscal Q3 Loss Widens, Revenue Falls
Nurix Therapeutics Fiscal Q3 Loss Widens, Revenue Falls
Oct 9, 2025
04:32 PM EDT, 10/09/2025 (MT Newswires) -- Nurix Therapeutics ( NRIX ) reported a fiscal Q3 net loss Thursday of $1.03 per diluted share, wider than a loss of $0.67 a year ago. Analysts polled by FactSet expected a GAAP loss of $0.84 per share and a loss of $0.82 a share. Revenue for the quarter ended Aug. 31 was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved